TRexBio prices $117M IPO at $14 per share (TRXB:Pending)
· seekingalpha.com
TRex Bio (TRXB), a clinical-stage biotechnology company focused on developing immunoregulatory medicines, priced its IPO at $14 per share,
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...